BAP1 and nonpapillary renal cell carcinoma: We note that our findings are in keeping with the observation of an aggressive subgroup of ccRCC with the concurrent loss of expression of PBRM1 and BAP1, a likely surrogate for the “multiple clonal drivers” subtype (Joseph et al., 2016).